Published in PLoS One on February 02, 2017
The epidemiology of osteosarcoma. Cancer Treat Res (2009) 5.10
Genome sequence of Staphylococcus aureus strain Newman and comparative analysis of staphylococcal genomes: polymorphism and evolution of two major pathogenicity islands. J Bacteriol (2007) 4.07
Septic arthritis. Lancet (1998) 3.76
Survival of Staphylococcus aureus inside neutrophils contributes to infection. J Immunol (2000) 3.08
Acute septic arthritis. Clin Microbiol Rev (2002) 2.17
Internalization of Staphylococcus aureus by cultured osteoblasts. Microb Pathog (1995) 2.03
Incidence and sources of native and prosthetic joint infection: a community based prospective survey. Ann Rheum Dis (1997) 1.83
Outbreak of spontaneous staphylococcal arthritis and osteitis in mice. Arthritis Rheum (1990) 1.75
Interleukin-6 and its receptor: from bench to bedside. Med Microbiol Immunol (2006) 1.65
The combination of a tumor necrosis factor inhibitor and antibiotic alleviates staphylococcal arthritis and sepsis in mice. J Infect Dis (2011) 1.61
Antibiotic-killed Staphylococcus aureus induces destructive arthritis in mice. Arthritis Rheumatol (2015) 1.56
Serum bone turnover markers (PINP and ICTP) for the early detection of bone metastases in patients with prostate cancer: a longitudinal approach. J Urol (2007) 1.52
Monitoring individual morphological changes over time in ovariectomized rats by in vivo micro-computed tomography. Bone (2006) 1.47
Staphylococcus aureus small colony variants are induced by the endothelial cell intracellular milieu. J Infect Dis (1996) 1.43
Pre-existing periodontitis exacerbates experimental arthritis in a mouse model. J Clin Periodontol (2011) 1.22
Bacterial osteomyelitis: findings on plain radiography, CT, MR, and scintigraphy. AJR Am J Roentgenol (1991) 1.17
Polyarticular septic arthritis. J Rheumatol (1986) 1.08
Markers of type I collagen degradation and synthesis in the monitoring of treatment response in bone metastases from breast carcinoma. Br J Cancer (1996) 1.03
Model systems: modeling human staphylococcal arthritis and sepsis in the mouse. Trends Microbiol (2001) 1.02
Acute changes in trabecular bone connectivity and osteoclast activity in the ovariectomized rat in vivo. J Bone Miner Res (1998) 1.01
An experimental model of cutaneous infection induced by superantigen-producing Staphylococcus aureus. J Invest Dermatol (2000) 0.99
Quantitative analysis of micro-CT imaging and histopathological signatures of experimental arthritis in rats. Mol Imaging (2004) 0.95
Application of in vivo micro-computed tomography in the temporal characterisation of subchondral bone architecture in a rat model of low-dose monosodium iodoacetate-induced osteoarthritis. Arthritis Res Ther (2011) 0.95
Usefulness of bone metabolic markers in the diagnosis and follow-up of bone metastasis from lung cancer. Br J Cancer (1997) 0.94
Imaging in early rheumatoid arthritis. Best Pract Res Clin Rheumatol (2013) 0.91
CTLA4 Immunoglobulin but Not Anti-Tumor Necrosis Factor Therapy Promotes Staphylococcal Septic Arthritis in Mice. J Infect Dis (2015) 0.88
Septic arthritis: immunopathogenesis, experimental models and therapy. J Venom Anim Toxins Incl Trop Dis (2014) 0.83
The use of nano-computed tomography to enhance musculoskeletal research. Connect Tissue Res (2015) 0.82
IL-1 Receptor Antagonist Treatment Aggravates Staphylococcal Septic Arthritis and Sepsis in Mice. PLoS One (2015) 0.79
Refine, reduce, replace: Imaging of fibrosis and arthritis in animal models. Best Pract Res Clin Rheumatol (2016) 0.79
Deficiency of the Complement Component 3 but Not Factor B Aggravates Staphylococcus aureus Septic Arthritis in Mice. Infect Immun (2016) 0.78
Prognostic factors associated with mortality in patients with septic arthritis: a descriptive cohort study. Scand J Rheumatol (2016) 0.77
The prognostic role of bone turnover markers in multiple myeloma patients: The impact of their assay. A systematic review and meta-analysis. Crit Rev Oncol Hematol (2015) 0.77
Tissue Plasminogen Activator Coating on Implant Surfaces Reduces Staphylococcus aureus Biofilm Formation. Appl Environ Microbiol (2015) 0.80
Deficiency of the Complement Component 3 but Not Factor B Aggravates Staphylococcus aureus Septic Arthritis in Mice. Infect Immun (2016) 0.78
Galectin-3 is a target for proteases involved in the virulence of Staphylococcus aureus. Infect Immun (2017) 0.75
Both anti-TNF and CTLA4 Ig treatments attenuate the disease severity of staphylococcal dermatitis in mice. PLoS One (2017) 0.75